22.04.2013.
European Medicines Agency publishes 2012 annual report The report highlights the main trends recently observed in the Agency’s activities. For the past few years, the Agency has received a stable number of initial marketing-authorisation applications (MAAs) for human medicines, with a total of 96 applications received in 2012. The Committee for Medicinal Products for Human Use (CHMP) issued 59 positive opinions for the approval of new medicines, including a positive opinion for the first gene therapy in Europe. |
